Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-18

FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)

View source ↗

Summary

The FDA approved a supplemental application for Ketoconazole filed by Thirty Madison Inc, resulting in updates to the Ketoconazole product labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole (Ketoconazole)

Snippet

SUPPL AP for KETOCONAZOLE (KETOCONAZOLE)